Insulin inhibits surfactant protein A and B gene expression in the H441 cell line

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1442, Issue 1, 1998, Pages 60-70

  Miakotina, Olga L ^a   Dekowski, Steven A ^a   Snyder, Jeanne M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Insulin; Lung; Surfactant protein; Surfactant associated protein B; Surfactant associated protein A

Indexed keywords

INSULIN; PROTEIN A; SURFACTANT;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; FETUS LUNG MATURATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HORMONE ACTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; RNA ANALYSIS;

ADENOCARCINOMA; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LUNG NEOPLASMS; PROTEOLIPIDS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; PULMONARY SURFACTANTS;

EUKARYOTA;

EID: 0032561443     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4781(98)00121-3     Document Type: Article

References (46)

1. Dobbs L.G. Pulmonary surfactant. Annu. Rev. Med. 40:1989;431-446.
2. Avery M.E., Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. Am. J. Dis. Child. 97:1959;517-523.
3. Jobe A.H. Pulmonary surfactant therapy. New Engl. J. Med. 328:1993;861-868.
4. Weaver T.E., Whitsett J.A. Function and regulation of expression of pulmonary surfactant-associated proteins. Biochem. J. 273:1991;249-264.
5. Hawgood S., Benson B.J., Hamilton R.L. Effects of a surfactant-associated protein and calcium ions on the structure and surface activity of lung surfactant lipids. Biochemistry. 24:1985;184-190.
6. Hawgood S., Benson J.B., Schilling J., Damm D., Clements J.A., White R.T. Nucleotide and amino acid sequences of pulmonary surfactant protein SP 18 and evidence for cooperation between SP 18 and SP 28-36 in surfactant lipid absorption. Proc. Natl. Acad. Sci. USA. 84:1987;66-70.
7. Suzuki Y., Fugita Y., Kogishi K. Reconstitution of tubular myelin from synthetic lipids and proteins associated with pig pulmonary surfactant. Am. Rev. Respir. Dis. 140:1989;75-81.
8. Thakur N.R., Tesan M., Tyler N.E., Bleasale J.E. Altered lipid synthesis in type II pneumonocytes exposed to lung surfactant. Biochem. J. 240:1986;679-690.
9. Kuroki Y., Mason R.J., Voelker D.R. Chemical modification of surfactant protein A alters high affinity binding to rat alveolar type II cells and regulation of phospholipid secretion. J. Biol. Chem. 263:1988;17596-17602.
10. Wright J.R., Wager R.E., Hawgood S., Dobbs L., Clements J.A. Surfactant apoprotein Mr 26,000=36,000 enhances uptake of liposomes by type II cells. J. Biol. Chem. 262:1987;2888-2894.
11. Van Golde L.M. Potential role of surfactant proteins A and D in innate lung defense against pathogens. Biol. Neonate. 67:1995;2-17.
12. Rice W.R., Sarin V.K., Fox J.L., Baatz J., Wert S., Whitsett J.A. Surfactant peptides stimulate uptake of phosphatidylcholine by isolated cells. Biochim. Biophys. Acta. 1006:1989;237-245.
13. Steinke J., Driscoll S.G. The extractable insulin of pancreas from fetuses and infants of diabetic and control mothers. Diabetes. 14:1965;573-578.
14. Heding L.G., Persson B., Stangenberg M. β-Cell function in newborn infants of diabetic mothers. Diabetologia. 19:1980;427-432.
15. Sosenko I.R., Kitzmiller J.L., Loo S.W., Blix P., Rubenstein A.H., Gabbay K.H. The infant of the diabetic mother. Correlation of increased cord C-peptide levels with macrosomia and hypoglycemia. New Engl. J. Med. 301:1979;859-862.
16. Robert M.G., Neff R.K., Hubbell J.P., Taeusch H.W., Avery M.E. Association between maternal diabetes and the respiratory-distress syndrome in the newborn. New Engl. J. Med. 294:1976;357-360.
17. Katyal S.L., Amenta J.S., Singh G., Silverman J.A. Deficient lung surfactant apoproteins in amniotic fluid with mature phospholipid profile from diabetic pregnancies. Am. J. Obstet. Gynecol. 148:1984;48-53.
18. Snyder J.M., Kwun J.E., O'Brien J.A., Rosenfeld C.R., Odom M.J. The concentration of the 35-kDa surfactant apoprotein in amniotic fluid from normal and diabetic pregnancies. Pediatr. Res. 24:1988;728-734.
19. Snyder J.M., Mendelson C.R. Insulin inhibits the accumulation of the major lung surfactant apoprotein in human fetal lung explants maintained in vitro. Endocrinology. 120:1987;1250-1257.
20. Dekowski S.A., Snyder J.M. Insulin regulation of mRNA for the surfactant-associated proteins in human fetal lung in vitro. Endocrinology. 131:1992;669-676.
21. Smith B.T. Lung maturation in the fetal rat: acceleration by injection of fibroblast pneumonocyte factor. Science. 204:1979;1094-1095.
22. Gazdar A.F., Limnoila R.I., Kurita Y., Die K.H., Mulshine J.L., Clark J.C., Whitsett J.A. Peripheral airway cell differentiation in human cancer cells. Cancer Res. 50:1990;5481-5487.
23. O'Reilly M.A., Weaver T.E., Pilot-Matias T.J., Sarin V.K., Gazdar A.F., Whitsett J.A. In vitro translation, post-translational processing and secretion of pulmonary surfactant protein B precursors. Biochim. Biophys. Acta. 1011:1989;140-148.
24. Whitsett J.A., Clark J.C., Wispe J.R., Pryhuber G.S. Effects of TNF-α and phorbol ester on human surfactant protein and MnSOD gene transcription. Am. J. Physiol. 262:1992;L688-L693.
25. O'Reilly M.A., Gazdar A.F., Morris R.E., Whitsett J.A. Differential effects of glucocorticoids on expression of surfactant protein in a human lung adenocarcinoma cell line. Biochim. Biophys. Acta. 970:1988;194-204.
26. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
27. Glasser S.W., Korfhagen T.R., Weaver T.E., Pilot-Matias T.J., Fox J.L., Whitsett J.A. cDNA and deduced amino acid sequence of human pulmonary surfactant-associated proteolipid SPL (Phe). Proc. Natl. Acad. Sci. USA. 84:1987;4007-4011.
28. White R.T., Damm D., Miller J., Spratt K., Schilling J., Hawgood S., Benson B., Cordell B. Isolation and characterization of the human pulmonary apoprotein gene. Nature. 317:1985;361-363.
29. Tao J.Y., Sun X., Kao T., Reece K.S., Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNA: genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 13:1985;2485-2502.
30. Metzler M.D., Snyder J.M. Retinoic acid differentially regulates expression of surfactant-associated proteins in human fetal lung. Endocrinology. 133:1993;1990-1998.
31. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
32. O'Reilly M.A., Clark J.C., Whitsett J.A. Glucocorticoid enhances pulmonary surfactant protein B gene transcription. Am. J. Physiol. 260:1991;L37-L43.
33. Iannuzzi D.M., Ertsey R., Ballard P.L. Biphasic glucocorticoid regulation of pulmonary SP-A: characterization of inhibitory process. Am. J. Physiol. 264:1993;L236-L244.
34. Boggaram V., Mendelson C.R. Transcriptional regulation of the gene encoding the major surfactant protein (SP-A) in rabbit fetal lung. J. Biol. Chem. 263:1988;19060-19065.
35. Sobell H. Actinomycin and DNA transcription. Proc. Natl. Acad. Sci. USA. 82:1985;5328-5331.
36. Chodish L.A., Fire A., Samuels M., Sharp P.A. 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase II in vitro. J. Biol. Chem. 264:1989;2250-2257.
37. Boggaram V., Smith M.E., Mendelson C.R. Posttranscriptional regulation of surfactant protein-A messenger RNA in human fetal lung in vitro by glucocorticoids. Mol. Endocrinol. 5:1991;414-423.
38. J.H. Zar, Biostatistical Analysis, Prentice-Hall, NJ, 1984.
39. Whitsett J.A., Budden A., Hull W.M., Clark J.C., O'Reilly M.A. Transforming growth factor-β inhibits surfactant protein A expression in vitro. Biochim. Biophys. Acta. 1123:1991;257-262.
40. Whitsett J.A., Weaver T.E., Lieberman M.A., Clark J.E., Daugherty C. Differential effects of epidermal growth factor and transforming growth factor-beta on synthesis of M=35,000 surfactant-associated protein in fetal lung. J. Biol. Chem. 262:1988;7908-7913.
41. Liley H.G., White R.T., Benson B.J., Ballard P.L. Glucocorticoids both stimulate and inhibit production of pulmonary surfactant protein A in fetal human lung. Proc. Natl. Acad. Sci. USA. 85:1988;9096-9100.
42. Liley H.G., White R.T., Warr R.G., Benson B.J., Hawgood S., Ballard P.L. Regulation of messenger RNAs for the hydrophobic surfactant proteins in human lung. J. Clin. Invest. 83:1989;1191-1197.
43. O'Brien R.M., Granner D.K. Regulation of gene expression by insulin. Biochem. J. 278:1991;609-619.
44. Katyal S.L., Singh G., Locker J. Characterization of a second human pulmonary surfactant-associated protein SP-A gene. Am. J. Respir. Cell Mol. Biol. 6:1992;446-450.
45. Pryhuber G.S., O'Reilly M.A., Clark J.C., Hull W.M., Fink I., Whitsett J.A. Phorbol ester inhibits surfactant protein SP-A and SP-B expression. J. Biol. Chem. 265:1990;20822-20828.
46. Shyu A.-B., Greenberg M.E., Belasco J.G. The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways. Genes Dev. 3:1989;60-72.